These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11593727)

  • 1. [Relationship between Noguchi's classification for small adenocarcinomas of the lung and tumor markers in serum].
    Watanabe A; Watanabe T; Tabata T; Takahashi K; Abe T; Abe S; Sato M; Kusajima K
    Kyobu Geka; 2001 Oct; 54(11):917-20. PubMed ID: 11593727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (Makimoto Y; Nabeshima K; Iwasaki H; Miyoshi T; Enatsu S; Shiraishi T; Iwasaki A; Shirakusa T; Kikuchi M
    Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorodeoxyglucose uptake correlates with the growth pattern of small peripheral pulmonary adenocarcinoma.
    Sagawa M; Higashi K; Sugita M; Ueda Y; Maeda S; Toga H; Sakuma T
    Surg Today; 2006; 36(3):230-4. PubMed ID: 16493531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung.
    Haneda H; Sasaki H; Shimizu S; Endo K; Suzuki E; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Lung Cancer; 2006 Apr; 52(1):47-52. PubMed ID: 16503085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intentional limited resection for lung adenocarcinoma of 2 cm in size or less according to intraoperative frozen section and high-resolution computed tomography].
    Saito H; Kiuchi R; Demura Y; Yashiki N; Masuda S; Kitagawa K
    Kyobu Geka; 2008 Jun; 61(6):444-8. PubMed ID: 18536290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.
    Sakao Y; Tomimitsu S; Takeda Y; Natsuaki M; Itoh T
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):520-2. PubMed ID: 15037265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frozen-section diagnosis of small adenocarcinoma of the lung for intentional limited surgery.
    Suda T; Mizoguchi Y; Hasegawa S; Negi K; Hattori Y
    Surg Today; 2006; 36(8):676-9. PubMed ID: 16865509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients.
    Muley T; Dienemann H; Ebert W
    Anticancer Res; 2004; 24(3b):1953-6. PubMed ID: 15274383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted magnetic resonance imaging in differentiating the invasiveness of small lung adenocarcinoma.
    Tanaka R; Horikoshi H; Yoshida T; Nakazato Y; Seki E; Goya T
    Acta Radiol; 2011 Sep; 52(7):750-5. PubMed ID: 21565888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
    Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
    Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intentional limited operation for minute peripheral adenocarcinoma of the lung].
    Kaji M; Morikawa T; Ohbuchi T; Ohtake S; Okushiba S; Kondo S; Katoh H
    Kyobu Geka; 2001 Oct; 54(11):951-5. PubMed ID: 11593734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acceptable definition of peripheral early lung cancer].
    Morita R; Suga M; Nakamura S; Kaneko K; Kyo S
    Kyobu Geka; 2001 Oct; 54(11):938-41. PubMed ID: 11593731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
    Molina R; Auge JM; Filella X; Viñolas N; Alicarte J; Domingo JM; Ballesta AM
    Anticancer Res; 2005; 25(3A):1773-8. PubMed ID: 16033098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High-resolution CT-pathologic correlation of small adenocarcinoma of the lung].
    Saito T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Apr; 58(5):197-203. PubMed ID: 9617154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR; Zhang X; Xu ZF; Zheng S
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA.
    Molina R; Filella X; Augé JM; Bosch E; Torne A; Pahisa J; Lejarcegui JA; Rovirosa A; Mellado B; Ordi J; Biete A
    Anticancer Res; 2005; 25(3A):1765-71. PubMed ID: 16033097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.